secwatch.observer — SEC 8-K summary
======================================

Issuer:     CorMedix Inc. (CRMD)
CIK:        0001410098
Form:       8-K
Filed at:   2021-10-29T23:59:59+00:00
Accession:  0001213900-21-055420
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CorMedix CFO Matt David appointed interim CEO; salary to $425k, bonus 60%
-------------------------------------------------------------------------

- Dr. David's base salary rises from $330k to $425k during interim CEO period; after, it resets to $375k.
- Target annual bonus increased to 60% of base salary while interim CEO; thereafter 40%.
- Severance extended to 12 months of base salary if terminated without cause during interim CEO role.
- Board grants Dr. David a stock option for 125,000 shares, vesting over four years.
- Board has initiated search with a leading executive firm for a permanent CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410098/000121390021055420/0001213900-21-055420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410098/000121390021055420/ea149576-8k_cormedix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-055420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer